These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 366978)

  • 1. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary fibrin degradation products--a three year comparative study.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Proc Eur Dial Transplant Assoc; 1978; 15():466-72. PubMed ID: 368788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of urinary fibrin degradation products.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Nephron; 1980; 25(1):25-9. PubMed ID: 6986037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary fibrin split products in lupus nephritis.
    Zizic TM; Cwazka WF; Young NS; Stevens MB
    J Rheumatol; 1976 Mar; 3(1):43-9. PubMed ID: 775087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of fibrinuria with fibrinogen split-product E following kidney allotransplantation.
    Zühlke V; Hölscher M; Reichel W; Pernice G
    Contrib Nephrol; 1975; 1():103-8. PubMed ID: 797519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC; Hockley M; Fenton SS; Wilson DR
    Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical value of the determination of urinary fibrin degradation products in the early management of renal transplants].
    André E; Kessler M; Briquel ME; Alexandre P; Hurault de Ligny B; Huriet C
    Sem Hop; 1983 Jun; 59(22):1669-73. PubMed ID: 6308788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practical interest of the determination of urinary fibrin degradation products in the early monitoring of kidney transplants].
    André E; Kessler M; Briquel ME; Alexandre P; Hurault de Ligny B; Huriet C
    Pathol Biol (Paris); 1983 Jan; 31(1):23-7. PubMed ID: 6343962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum and urine fibrin split products and urinary beta-glucuronidase in the diagnosis of renal transplant rejection.
    Gonick HC; Stiehm ER; Saldanha LF
    Curr Probl Clin Biochem; 1979; (9):257-72. PubMed ID: 376226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrin/figrinogen degradation products in the urine in children with glomerulonephritis and pyelonephritis].
    Utetleuov B
    Pediatriia; 1977 Feb; (2):22-4. PubMed ID: 865971
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of formation and diagnostic value of fibrin fibrinogen split products in kidney allotransplantation].
    Drannik GN
    Urol Nefrol (Mosk); 1979; (2):62-9. PubMed ID: 375530
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrin fibrinogen degradation products in the urine of patients with kidney transplantations].
    Leithner C; Oppolzer R; Wolf A; Pinggera W; Stummvoll HK
    Wien Med Wochenschr; 1975 Oct; 125(41):598-9. PubMed ID: 775807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)].
    Bouissou F; Barthe P; Boneu B
    Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
    Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation.
    Ekberg M; Bergentz SE; Hedner U; Nilsson IM
    Scand J Urol Nephrol; 1976; 10(1):56-62. PubMed ID: 775625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.